LMNA and laminopathy: Importantly, treatment with rapamycin, which is a specific mTOR-inhibitor, contributed to an improvement of LMNA–/– mice phenotypes and an elevation of survival, showing that mTOR activation might mediate phenotypes involved in laminopathy diseases.